Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke

This publication has 15 references indexed in Scilit:

• European Stroke Initiative Recommendations for Stroke Management
  Cerebrovascular Diseases, 2000
• Anticoagulants for acute ischaemic stroke
  Published by Wiley ,1999
• Antithrombotic Drugs:Insights f rom Cardiology
  Cerebrovascular Diseases, 1998
• Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke: A Randomized Controlled Trial
  JAMA, 1998
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
  Published by Elsevier ,1997
• Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke
  New England Journal of Medicine, 1995
• Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
  The Lancet, 1993
• Effects of Ticlopidine on the Neurologic Outcome and the Hemorheologic Pattern in the Postacute Phase of Ischemic Stroke: A Pilot Study
  Angiology, 1990
• Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke: A Randomized Controlled Trial
  Annals of Internal Medicine, 1986
• LOW-DOSE SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS AND PULMONARY EMBOLI FOLLOWING ACUTE STROKE
  Age and Ageing, 1986